Question ID
2014_1506
Legal act
Regulation (EU) No 575/2013 (CRR)
Topic
Market risk
Article
327
Paragraph
1
COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations
Not applicable
Article/Paragraph
-
Type of submitter
Investment firm
Subject matter
Treatment of contracts for difference under Article 327(1) or Regulation (EU) No 575/2013 (CRR)
Question

Shall financial contracts for difference be treated as exposure in an underlying instrument?

Background on the question

Treatment of financial contracts for difference (MiFID, Annex I, Section C, Point 9) is not described in Article 327 of CRR, although treatment of the other derivative categories is described. As they are different MiFID category than futures, options, warrants etc., it is not clear how they shall be treated.

Submission date
Final publishing date
Final answer

As per point 3 of Annex II to Regulation (EU) No 575/2013 (CRR), instruments specified in points 4 to 7, 9 and 10 of Section C of Annex I to Directive (EU) 2004/39/EC (MiFID) are a type of derivative. Point 9 in Section C of Annex 1 to MiFID is financial contracts for differences (CFDs). Hence, as per the CRR, financial CFDs are a type of derivative and should be treated as such for regulatory purposes.

A CFD can be considered as a derivative which synthetically replicates the performance of the underlying which means that the market risk is identical with a position in the underlying itself. Therefore CFDs should be treated as exposure to the amount of the underlying instrument to which they refer.

Status
Final Q&A
Answer prepared by
Answer prepared by the EBA.
Note to Q&A

Update 26.03.2021: This Q&A has been reviewed in the light of the changes introduced to Regulation (EU) No 575/2013 (CRR) and continues to be relevant.

Disclaimer

The Q&A refers to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.